tradmap

EWTX Earnings Edgewise Therapeutics, Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$23 -$12 $0 2020 2021 2022 2023 2024 2025
EPS
Net income (annual)
-$68M -$34M $0 2020 2021 2022 2023 2024 2025
Net income
Return on equity (annual)
-20% 16% 51% 0% 2020 2021 2022 2023 2024 2025
ROE

Quarterly results

Diluted EPS (quarterly)
-$1 -$1 $0 Q3 '22 Q2 '23 Q1 '24 Q3 '24 Q2 '25 Q1 '26
EPS
Net income (quarterly)
-$50M -$25M $0 Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25
Net income
Return on equity (quarterly)
-10% -5% 0% Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25
ROE

Reported EPS history

1–23 of 23
Q2 20262026-06-30-0.992026-08-0610-Q
Q1 20262026-03-31-0.462026-05-0710-Q
FY 20252025-12-31-1.632026-02-2610-K
Q3 20252025-09-30-1.152025-11-0610-Q
Q2 20262025-06-30-0.772026-08-0610-Q
Q1 20262025-03-31-0.432026-05-0710-Q
FY 20252024-12-31-1.452026-02-2610-K
Q3 20252024-09-30-1.032025-11-0610-Q
Q2 20252024-06-30-0.662025-08-0710-Q
Q1 20252024-03-31-0.332025-05-0810-Q
FY 20252023-12-31-1.572026-02-2610-K
Q3 20242023-09-30-1.102024-11-0710-Q
Q2 20242023-06-30-0.702024-08-0810-Q
Q1 20242023-03-31-0.362024-05-0910-Q
FY 20232022-12-31-1.262024-02-2210-K
Q3 20232022-09-30-0.962023-11-0910-Q
Q2 20232022-06-30-0.622023-08-1010-Q
Q1 20232022-03-31-0.302023-05-1110-Q
FY 20222021-12-31-1.142023-02-2310-K
Q3 20222021-09-30-0.902022-11-0310-Q
Q2 20222021-06-30-0.672022-08-0410-Q
Q1 20222021-03-31-4.372022-05-1110-Q
FY 20212020-12-31-23.172022-02-2410-K

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.